2022 | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
| GUT AND LIVER |
2016 | Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes
| YONSEI MEDICAL JOURNAL |
2015 | Chronic HMGCR/HMG-CoA Reductase Inhibitor Treatment Contributes to Dysglycemia by Upregulating Hepatic Gluconeogenesis through Autophagy Induction | AUTOPHAGY |
2011 | Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans
| EUROPEAN JOURNAL OF ENDOCRINOLOGY |
2006 | Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea | METABOLISM-CLINICAL AND EXPERIMENTAL |
2023 | Clinical Effects of a Home Care Pilot Program for Patients with Type 1 Diabetes Mellitus: A Retrospective Cohort Study
| DIABETES & METABOLISM JOURNAL |
2018 | Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes | DIABETES & METABOLISM |
2017 | Clinical parameters affecting dapagliflozin response in patients with type 2 diabetes | DIABETES & METABOLISM |
2020 | Cohort Profile: Firefighter Research on the Enhancement of Safety and Health (FRESH), a Prospective Cohort Study on Korean Firefighters
| YONSEI MEDICAL JOURNAL |
2018 | Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus
| FRONTIERS IN ENDOCRINOLOGY |
2020 | Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name | METABOLISM-CLINICAL AND EXPERIMENTAL |
2015 | Comparing kidney outcomes in type 2 diabetes treated with different sulphonylureas in real-life clinical practice | DIABETES & METABOLISM |
2016 | Comparison and Validation of 10 Equations Including a Novel Method for Estimation of LDL-cholesterol in a 168,212 Asian Population
| MEDICINE |
2017 | Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes.
| Endocrinology and Metabolism (대한내분비학회지) |
2006 | Comparison of Body Fat Composition and Serum Adiponectin Levels in Diabetic Obesity and Non-diabetic Obesity | OBESITY |
2022 | Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
| DIABETES & METABOLISM JOURNAL |
2019 | Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide | Diabetes & Metabolism |
2020 | Comparison of Renal Effects of Ezetimibe-Statin Combination Versus Statin Monotherapy: A Propensity-Score-Matched Analysis
| JOURNAL OF CLINICAL MEDICINE |
2018 | Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis
| Endocrinology and Metabolism (대한내분비학회지) |
2020 | Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis | METABOLISM-CLINICAL AND EXPERIMENTAL |
2019 | Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea
| Endocrinology and Metabolism (대한내분비학회지) |
2022 | DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice
| DIABETES & METABOLISM JOURNAL |
2006 | Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes
| EUROPEAN JOURNAL OF ENDOCRINOLOGY |
2016 | Depot-Specific Changes in Fat Metabolism with Aging in a Type 2 Diabetic Animal Model
| PLOS ONE |
2007 | Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model | METABOLISM-CLINICAL AND EXPERIMENTAL |
2007 | Design, synthesis, and discovery of stilbene derivatives based on lithospermic acid B as potent protein tyrosine phosphatase 1B inhibitors | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS |
2017 | Diabetes self-assessment score and the development of diabetes A 10-year prospective study
| MEDICINE |
2010 | Dietary monounsaturated fatty acids but not saturated fatty acids preserve the insulin signaling pathway via IRS-1/PI3K in rat skeletal muscle | LIPIDS |
2011 | Dietary oleate has beneficial effects on every step of non-alcoholic Fatty liver disease progression in a methionine- and choline-deficient diet-fed animal model.
| DIABETES & METABOLISM JOURNAL |
2018 | Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study
| SCIENTIFIC REPORTS |
2020 | Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in Vitro and in Vivo
| JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS |
2019 | Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis
| DIABETES THERAPY |
2012 | Dimethyl sulfoxide reduces hepatocellular lipid accumulation through autophagy induction
| AUTOPHAGY |
2020 | Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
| SCIENTIFIC REPORTS |
2013 | Discovery of DiPeptidyl Peptidase-4 Gene Variants and the Associations with Efficacy of Vildagliptin in Patients with Type 2 Diabetes - A Pilot Study
| JOURNAL OF DIABETES & METABOLISM |
2006 | Does birthweight predict adolescent adiponectin levels? | CLINICAL ENDOCRINOLOGY |
2008 | Echogenic carotid artery plaques are associated with vertebral fractures in postmenopausal women with low bone mass. | CALCIFIED TISSUE INTERNATIONAL |
2016 | Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea
| PLOS ONE |
2009 | Effect of ABCA1 variant on atherogenic dyslipidaemia in patients with Type 2 diabetes treated with rosiglitazone | DIABETIC MEDICINE |
2014 | Effect of cilostazol on carotid intima-media thickness in type 2 diabetic patients without caridiovascular event | ENDOCRINE |
2020 | Effect of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on gluconeogenesis in proximal renal tubules | DIABETES OBESITY & METABOLISM |
2020 | Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue
| BIOMEDICINES |
2017 | Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study | INTERNATIONAL JOURNAL OF CANCER |
2020 | Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
| DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY |
2016 | Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study
| Endocrinology and Metabolism (대한내분비학회지) |
2006 | Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control | CLINICAL ENDOCRINOLOGY |
2011 | Effects of leptin and adiponectin on pancreatic β-cell function | METABOLISM-CLINICAL AND EXPERIMENTAL |
2006 | Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus | METABOLISM-CLINICAL AND EXPERIMENTAL |
2018 | Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db mice | INTERNATIONAL JOURNAL OF OBESITY |
2016 | Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia.
| PLOS ONE |
2010 | Effects of pioglitazone on subclinical atherosclerosis and insulin resistance in nondiabetic renal allograft recipients.
| NEPHROLOGY DIALYSIS TRANSPLANTATION |
2005 | Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 gene on rosiglitazone response in type 2 diabetes | CLINICAL PHARMACOLOGY & THERAPEUTICS |
2007 | Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus | CLINICAL ENDOCRINOLOGY |
2018 | Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer
| Endocrinology and Metabolism (대한내분비학회지) |
2023 | Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
| DIABETES & METABOLISM |
2020 | Efficacy and Safety of Gemigliptin as Add-On Therapy to Insulin, With or Without Metformin, in Patients With Type 2 Diabetes Mellitus (ZEUS II Study) | DIABETES OBESITY & METABOLISM |
2019 | Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus | TRANSPLANTATION PROCEEDINGS |
2020 | Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naïve people with type 2 diabetes: The EDITION AP randomized controlled trial | DIABETES OBESITY & METABOLISM |
2016 | Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis
| MEDICINE |
2018 | Elevated N-acetyl-beta-D-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study | JOURNAL OF DIABETES AND ITS COMPLICATIONS |